Hostname: page-component-76fb5796d-r6qrq Total loading time: 0 Render date: 2024-04-27T03:30:22.911Z Has data issue: false hasContentIssue false

Evoked far-field potentials originating from the brainstem – new diagnostic possibilities for alzheimer's disease?

Published online by Cambridge University Press:  16 April 2020

A.J. Fallgatter
Affiliation:
Department of Psychiatry and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany
F. Metzger
Affiliation:
Department of Psychiatry and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany
A.C. Ehlis
Affiliation:
Department of Psychiatry and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany
M.J. Herrmann
Affiliation:
Department of Psychiatry and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany
J. Langer
Affiliation:
Department of Psychiatry and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany
T. Polak
Affiliation:
Department of Psychiatry and Psychotherapy, University of Wuerzburg, Wuerzburg, Germany

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Background and aims:

Recently, the vagus nuclei in the brainstem have come into the focus of interest in psychiatric and neurological research mainly for two reasons: Firstly, their function is altered early in the course of Alzheimer's disease (AD; Parvizi et al., 2001). Secondly, in a small pilot study the electrical stimulation of the left vagus nerve in the neck by means of an implanted stimulator has shown to improve cognitive impairments in patients with AD (Sjogren et al., 2002).

Methods:

Based on these findings a method for the non-ionvasive measurement of far-field potentials from the vagus nuclei evoked by means of an electrical stimulation via a peripheral branch of the nerve in the outer ear is a potentially interesting diagnostic procedure.

Results:

Vagus Sensory Evoked Potentials (VSEP) can be elicited in a reliable manner in younger and elderly healthy subjects. VSEP-latencies have been found to increase with age in healthy subjects. In a first clinical application, VSEP-latencies in patients with mild to moderate AD were found to be prolonged as compared to age-matched healthy participants.

Conclusions:

This new, none-invasive measure is very easy to apply and may be a disease marker for AD, possibly also in preclinical stages. Further studies are necessary which systematically investigate changes in VSEP measures in patients with neurodegenerative disorders in order to elucidate their diagnostic specifity and validity.

Type
Poster Session 2: Organic Mental Disorders and Memory and Cognitive Dysfunctions
Copyright
Copyright © European Psychiatric Association 2007
Submit a response

Comments

No Comments have been published for this article.